Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 35.6Yield –
Vertex Pharmaceuticals Non-GAAP provision for income taxes by Year
Non-GAAP provision for income taxes ($M) ($M)
Vertex Pharmaceuticals Non-GAAP provision for income taxes: $991M in FY2025, down 11.8% from a year earlier.
Where the FY2025 figure comes from
“|| Non-GAAP provision for income taxes | $ | 200.9 | $ | 279.7 | $ | 991.0 | $ | 1,124.1”
Source: Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (GAAP to Non-GAAP Reconciliations).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP provision for income taxes ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 991 | -11.8% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 1,124 | +17.7% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 955 | -5.7% | Form 8-K (ex-991_q42024.htm, filed 2025-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 1,012 | +55.7% | Form 8-K (ex-991_q42023.htm, filed 2024-02-05) ↗ |
| FY2021 | Dec 31, 2021 | 650 | -9.8% | Form 8-K (ex-991_q42022.htm, filed 2023-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 721 | +81.7% | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 397 | +2,318.9% | Form 8-K (ex-991_q42020.htm, filed 2021-02-01) ↗ |
| FY2018 | Dec 31, 2018 | 16.4 | +141.2% | Form 8-K (ex-991q42019.htm, filed 2020-01-30) ↗ |
| FY2017 | Dec 31, 2017 | 6.80 | – | Form 8-K (ex-991_q42018.htm, filed 2019-02-05) ↗ |
Breakdown
What makes up non-GAAP provision for income taxes
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP provision for income taxes ($M), annual FY2017–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-tax
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.